title: Radiation therapy to non-iatrogenic subcutaneous metastasis in hepatocellular carcinoma: results of a case series.
abstract: Non-iatrogenic subcutaneous metastasis of hepatocellular carcinoma (HCC) is rare. The aim of this study was to determine the characteristics of such non-iatrogenic subcutaneous metastases and to review the results of radiation therapy. Patients with HCC who were referred for radiation therapy to a subcutaneous mass from 1 January 1998 to 31 December 2005 were reviewed. Iatrogenic cases were excluded. The patients' characteristics, the properties of the lesion, radiation treatment, treatment response, and survival were studied. 24 subcutaneous metastatic lesions in 21 patients were studied. The patients' mean age was 58.2 years. The average latency period for the occurrence of the metastases was 291 days. The scalp was the most frequent metastatic site. At least a partial response was achieved in 20 of 24 lesions (83.3%), with radiation doses ranging from 8 to 64 Gy. No severe sequelae were recorded. The overall 6-month survival was 43.4%. ECOG (Eastern Cooperative Oncology Group) performance status and radiation dose were statistically significant factors for local treatment response. Performance status was also an independent factor for survival. Radiation therapy of subcutaneous metastases of HCC can achieve satisfactory results, especially in patients with a good performance status.
authors.affiliation: Department of Radiation Oncology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan. yjhuang@adm.cgmh.org.tw
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Huang
authors.forename: W-C
authors.initials: WC
authors.lastname: Tung
authors.forename: H-C
authors.initials: HC
authors.lastname: Hsu
authors.forename: C-Y
authors.initials: CY
authors.lastname: Wang
authors.forename: E-Y
authors.initials: EY
authors.lastname: Huang
authors.forename: F-M
authors.initials: FM
authors.lastname: Fang
mesh_terms: D000005:Abdomen; D001415:Back; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D005260:Female; D005542:Forearm; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000556:secondary; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D018709:Statistics, Nonparametric; D015996:Survival Rate; D013909:Thorax; D016896:Treatment Outcome